Navigation Links
UNC shares $6 million Leducq award to study heart failure
Date:9/30/2011

(Embargoed) CHAPEL HILL, N.C. A collaborative network of European and North American scientists, including from the University of North Carolina at Chapel Hill School of Medicine, have been awarded a total of $6 million over five years to explore the biology of heart failure and to find new therapies for it.

The grant was awarded by Fondation Leducq Transatlantic Networks of Excellence Program, headquartered in Paris, France. Fondation Leducq is a French non-profit health research foundation, which is designed to promote collaborative research involving centers in North America and Europe in the areas of cardiovascular and neurovascular disease.

"Proteotoxicity: an unappreciated mechanism of heart disease and its potential for novel therapeutics" is the title of this network's award-winning project. "Proteotoxicity" refers to potential health consequences due to the failure of cells to degrade and clear intracellular aggregated proteins. This may include misshapen or misfolded proteins that could, for instance, disrupt intracellular messages and impede chemical reactions.

"Recent discoveries suggest that the failure to clear aggregated proteins is a major factor in hereditary and acquired cardiac and skeletal muscle diseases," said Network of Excellence Core member, Cam Patterson, MD, MBA, Ernest and Hazel Craige Distinguished Professor of Medicine and cardiology division chief at UNC. "This network is the first to harness the synergy between skeletal and cardiac muscle research in the emerging area of cardiac protein turnover and proteotoxicity by including experts in both fields."

The project's 3 main research aims are to (1) define the role of proteotoxicity in clinically relevant models of heart failure, (2) determine the networks of genes and gene products operating in cardiac muscle cell protein degradation and aggregation, (3) explore novel interventions to reduce and/or block proteotoxicity in animal models of cardiomyopathy and heart failure.

Sharing the new award with Patterson at UNC are network members Jeff Robbins, PhD at Cincinnati Children's Hospital in Ohio; Mathias Gautel, MD, PhD at King's College in London, England; Lucie Carrier, PhD, at the University Medical Center Hamburg-Eppendorf, in Hamburg, Germany; Marco Sandri, MD, PhD at the Venetian Institute of Molecular Medicine and University of Padova, Padova, Italy; and Joseph A. Hill, MD, PhD at the University of Texas Southwestern Medical Center, Dallas, Texas.

Since 2004 when grants were first awarded under the Transatlantic Networks of Excellence in Cardiovascular Research Program, 31 collaborative networks have been selected for Leducq support, representing more than 300 investigators at 115 institutions in 17 countries, with research interests spanning from heart failure to cerebral hemorrhage.


'/>"/>

Contact: Les Lang
llang@med.unc.edu
919-966-9366
University of North Carolina School of Medicine
Source:Eurekalert  

Related medicine news :

1. Internationally acclaimed immunologist shares $1 million Shaw Prize
2. Expert Shares Spring Break Safety Tips
3. John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques
4. Child soldier trauma in Uganda shares similarities with Northern Ireland
5. Self-Published Author Shares Her Personal Story of Hope Amidst Despair
6. Retirement Options Shares Tips for Retiring Happy Regardless of Income
7. Webinar Shares Proven Social Media Approach to BtoB Lead Generation
8. Micromet Announces Pricing of Public Offering of 10 Million Shares of Common Stock
9. Cincinnati Childrens earns $12 million NIH grant to test migraine prevention medicines
10. Scripps research scientist wins $3.6 million NIH Method to Extend Research in Time award to study alcoholism in Native Americans
11. Wayne State researcher developing treatments for Parkinsons with aid of $2.15 million NIH grant
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UNC shares $6 million Leducq award to study heart failure
(Date:3/29/2017)... ... March 29, 2017 , ... Curio Wellness , a ... the finalization of the company’s executive management team with prominent executives from both inside ... Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who has more than twenty ...
(Date:3/29/2017)... ... March 29, 2017 , ... Hamlin Dental Group, multi-location dental office in ... treatments. Dental lasers are safe and effective options, and can be used alone or ... the overall quality of care. , Dr. Hamid Reza of Hamlin Dental Group offers ...
(Date:3/29/2017)... ... ... has helped over 1.5 million SharePoint users learn the content management system faster and ... for SharePoint was at the farm level. Enterprises using SharePoint Online in Office 365 ... recently released a modified version of the Help System, VisualSP for Site Collections, which ...
(Date:3/28/2017)... ... March 28, 2017 , ... Greenfield Advisors is ... his extensive knowledge of appraisals, property values, ad valorem taxation, and government policy ... industry for more than 40 years. , “Ruel is a great addition to ...
(Date:3/28/2017)... ... 28, 2017 , ... City trips have soared 82% since ... Report). As travelers visit both urban destinations, they are faced with exploration that ... In response, the outdoor industry has blurred the lines between fashion and function ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... -- The Pharmaceutical Care Management Association (PCMA) today released the ... out-of-pocket spending: According to ... average amount spent out-of-pocket for drugs continues to decline, ... down from 23% in 2006. Rising ... problem. Health plans don,t have unlimited funds to pay ...
(Date:3/29/2017)... 2017 Research and Markets has announced the ... 2023" report to their offering. ... The ablation device global market is expected ... by 2023. Ablation is the minimally invasive therapeutic ... cancerous or diseased tissue removal, to the removal of abnormally conducting ...
(Date:3/29/2017)... 29, 2017  Spiral Therapeutics, Inc. today announced ... Farma, S.L. for the worldwide exclusive rights to ... the field of otolaryngology for aggregate payments of ... The agreement provides Spiral with the option to ... product profile. Under the terms of the agreement, ...
Breaking Medicine Technology: